FGF23 and bone disorder: FGF-23 is mainly secreted by osteocytes and osteoblasts and is upregulated in the circulation in cases of bone disorders characterized by softening and weakening of bones (low bone mineral density) including all types of hypophosphatemic rickets (Guo and Yuan, 2015).